- Home
- VRNA vs IDA Comparison
VRNA vs IDA Comparison
Compare VRNA & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- IDA
- Stock Information
- Founded
- VRNA 2005
- IDA 1915
- Country
- VRNA United Kingdom
- IDA United States
- Employees
- VRNA N/A
- IDA N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- IDA Electric Utilities: Central
- Sector
- VRNA Health Care
- IDA Utilities
- Exchange
- VRNA Nasdaq
- IDA Nasdaq
- Market Cap
- VRNA 8.3B
- IDA 7.0B
- IPO Year
- VRNA 2017
- IDA N/A
- Fundamental
- Price
- VRNA $106.91
- IDA $133.29
- Analyst Decision
- VRNA Buy
- IDA Buy
- Analyst Count
- VRNA 11
- IDA 7
- Target Price
- VRNA $114.10
- IDA $123.29
- AVG Volume (30 Days)
- VRNA 1.5M
- IDA 412.5K
- Earning Date
- VRNA 11-03-2025
- IDA 10-30-2025
- Dividend Yield
- VRNA N/A
- IDA 2.57%
- EPS Growth
- VRNA N/A
- IDA 6.48
- EPS
- VRNA N/A
- IDA 5.70
- Revenue
- VRNA $221,673,000.00
- IDA $1,809,996,000.00
- Revenue This Year
- VRNA $909.96
- IDA $5.11
- Revenue Next Year
- VRNA $76.47
- IDA $8.96
- P/E Ratio
- VRNA N/A
- IDA $23.46
- Revenue Growth
- VRNA N/A
- IDA N/A
- 52 Week Low
- VRNA $31.09
- IDA $99.81
- 52 Week High
- VRNA $106.94
- IDA $134.81
- Technical
- Relative Strength Index (RSI)
- VRNA 72.60
- IDA 72.67
- Support Level
- VRNA $105.78
- IDA $129.93
- Resistance Level
- VRNA $106.86
- IDA $134.35
- Average True Range (ATR)
- VRNA 0.16
- IDA 1.89
- MACD
- VRNA -0.04
- IDA 0.54
- Stochastic Oscillator
- VRNA 98.26
- IDA 85.58
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.